Fund Overview
ETF
Mirae Asset Nifty 500 Healthcare ETF
Ticker: HEALTHCAREUnderlying Index: Nifty500 HealthcareISIN: INF769K01QA6
19.97—
End of Day NAV as on Oct 23, 2026
Fundamentals
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 50 Companies |
| Market Cap Focus | Multi / Flexi Cap |
| Std Deviation (1 yr) | 0.87% |
| P/E | 58.29 |
| P/B | 8.74 |
| Div Yield | 0.47% |
| Down from 52w High | 16.09% |
| Up from 52w Low | 16.24% |
| Asset Type | Equity |
| Underlying Index Type | Sectoral Index |
| No. of Companies | 50 |
| Market Cap Focus | Multi / Flexi Cap |
| P/E | 58.29 |
| P/B | 8.74 |
| Div Yield | 0.47% |
| Down from 52w High | 16.09% |
| Up from 52w Low | 16.24% |
| Std Deviation (1 yr) | 0.87% |
Fund Parameters
| AUM (Cr) | 15 |
| Base Expense Ratio | 0.16% |
| Tracking Error | 0.01% |
| All-In-Cost | 0.17% |
| Inception Date | 10 Feb 2026 |
| Scheme Option - Type | Growth - Open ended scheme |
| Latest Price | 19.90 |
| NAV Gap | -0.35% |
| 1M Average NAV Gap | -0.06% |
| Daily Volume | 36,939 |
| 1M Average Daily Volume | 45,921 |
| 1M Average Daily Turnover (Cr) | 0.1 |
Native Score
| AUM (Cr) | 15 |
| Base Expense Ratio | 0.16% |
| Tracking Error | 0.01% |
| All-In-Cost | 0.17% |
| Inception Date | 10 Feb 2026 |
| Scheme Option - Type | Growth - Open ended scheme |
| ETF Market Data | |
| Latest Price | 19.90 |
| NAV Gap | -0.35% |
| 1M Avg NAV Gap | -0.06% |
| Daily Volume | 36,939 |
| 1M Avg Daily Volume | 45,921 |
| 1M Avg Daily Turnover | 0.1 |
| Native Score | |
Similar Exchange Traded Funds (ETFs)
No similar exchange traded funds (etfs) available for this index
Similar Index Funds
No similar index funds available for this index
Sectoral Allocation
Total
100%
allocation
- Healthcare99.4%
- Business Services0.5%
- Miscellaneous0.1%
- Healthcare99.4%
- Business Services0.5%
- Miscellaneous0.1%
Fund Holdings
| Name | Weight |
|---|
| Sun Pharmaceutical Industries Ltd. | 10.1% |
| Divi's Laboratories Ltd. | 8.8% |
| Apollo Hospitals Enterprise Ltd. | 6.2% |
| Laurus Labs Ltd. | 5.7% |
| Cipla Ltd. | 5.6% |
| Dr. Reddy's Laboratories Ltd. | 5.6% |
| Torrent Pharmaceuticals Ltd. | 5.2% |
| Max Healthcare Institute Ltd. | 5.1% |
| Lupin Ltd. | 3.7% |
| Aurobindo Pharma Ltd. | 3.4% |
| Fortis Healthcare Ltd. | 3.0% |
| Glenmark Pharmaceuticals Ltd. | 2.6% |
| Alkem Laboratories Ltd. | 2.3% |
| Zydus Lifesciences Ltd. | 2.1% |
| Mankind Pharma Ltd. | 2.1% |
| Ipca Laboratories Ltd. | 2.0% |
| Biocon Ltd. | 1.9% |
| Gland Pharma Ltd. | 1.7% |
| Sai Life Sciences Ltd. | 1.6% |
| Krishna Institute of Medical Sciences Ltd | 1.5% |
| Aster DM Quality Care Ltd. | 1.4% |
| Neuland Laboratories Ltd. | 1.4% |
| Wockhardt Ltd. | 1.3% |
| Acutaas Chemicals Ltd. | 1.3% |
| Ajanta Pharma Ltd. | 1.2% |
| Dr. Lal Pathlabs Ltd. | 1.1% |
| Abbott India Ltd. | 1.0% |
| Piramal Pharma Ltd. | 1.0% |
| Granules India Ltd. | 0.9% |
| Narayana Hrudayalaya Ltd. | 0.9% |
| Global Health Ltd. | 0.9% |
| Onesource Specialty Pharma Ltd. | 0.9% |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.8% |
| Anthem Biosciences Ltd. | 0.7% |
| Emcure Pharmaceuticals Ltd. | 0.6% |
| Natco Pharma Ltd. | 0.6% |
| Cohance Lifesciences Ltd. | 0.5% |
| Vijaya Diagnostic Centre Ltd. | 0.5% |
| Syngene International Ltd. | 0.5% |
| Rainbow Children's Medicare Ltd. | 0.5% |
| Poly Medicure Ltd. | 0.5% |
| Rubicon Research Ltd. | 0.4% |
| Caplin Point Laboratories Ltd. | 0.4% |
| Concord Biotech Ltd. | 0.3% |
| Tri-Party Repo (TREPS) | 0.1% |
| Net Current Asset | -0.1% |
NameWeight
Sun Pharmaceutical Industries Ltd.10.1%
Divi's Laboratories Ltd.8.8%
Apollo Hospitals Enterprise Ltd.6.2%
Laurus Labs Ltd.5.7%
Cipla Ltd.5.6%
Dr. Reddy's Laboratories Ltd.5.6%
Torrent Pharmaceuticals Ltd.5.2%
Max Healthcare Institute Ltd.5.1%
Lupin Ltd.3.7%
Aurobindo Pharma Ltd.3.4%
Fortis Healthcare Ltd.3.0%
Glenmark Pharmaceuticals Ltd.2.6%
Alkem Laboratories Ltd.2.3%
Zydus Lifesciences Ltd.2.1%
Mankind Pharma Ltd.2.1%
Ipca Laboratories Ltd.2.0%
Biocon Ltd.1.9%
Gland Pharma Ltd.1.7%
Sai Life Sciences Ltd.1.6%
Krishna Institute of Medical Sciences Ltd1.5%
Aster DM Quality Care Ltd.1.4%
Neuland Laboratories Ltd.1.4%
Wockhardt Ltd.1.3%
Acutaas Chemicals Ltd.1.3%
Ajanta Pharma Ltd.1.2%
Dr. Lal Pathlabs Ltd.1.1%
Abbott India Ltd.1.0%
Piramal Pharma Ltd.1.0%
Granules India Ltd.0.9%
Narayana Hrudayalaya Ltd.0.9%
Global Health Ltd.0.9%
Onesource Specialty Pharma Ltd.0.9%
Glaxosmithkline Pharmaceuticals Ltd.0.8%
Anthem Biosciences Ltd.0.7%
Emcure Pharmaceuticals Ltd.0.6%
Natco Pharma Ltd.0.6%
Cohance Lifesciences Ltd.0.5%
Vijaya Diagnostic Centre Ltd.0.5%
Syngene International Ltd.0.5%
Rainbow Children's Medicare Ltd.0.5%
Poly Medicure Ltd.0.5%
Rubicon Research Ltd.0.4%
Caplin Point Laboratories Ltd.0.4%
Concord Biotech Ltd.0.3%
Tri-Party Repo (TREPS)0.1%
Net Current Asset-0.1%
Holdings Concentration
Total covered: 100%
Top 1–5
5 holdings
36.5%
36%
share
Top 6–10
5 holdings
23.0%
23%
share
Top 11–20
10 holdings
20.8%
21%
share
Beyond 20
25 holdings
19.8%
20%
share
Market Cap Classification
Total
100%
allocation
- Mid Cap45.6%
- Large Cap36.0%
- Small Cap18.3%
- Mid Cap45.6%
- Large Cap36.0%
- Small Cap18.3%
Advanced Ratios
| Alpha | -0.00 |
| Beta | 1.00 |
| Sharpe Ratio | 0.10 |
| Sortino Ratio | 0.17 |
| Treynor Ratio | 0.09 |
| Information Ratio | -0.15 |
| Upside Capture | 99.61% |
| Downside Capture | 100.04% |
Index Methodology
| Factor Basis | Sector/Theme |
| What universe selected from? | Nifty 500 Index which represent Healthcare sector. |
| Weightage? | Free-Float Market Cap Weighting; Max weight = 10% |
| Stocks Included | Top 50 companies from Nifty 500's Healthcare sector, ranked by 6-month average free-float market cap, preference to F&O-traded stocks followed by non-F&O stocks if required. |
| Exclusions | Stocks moving out of Nifty 500, trading frequency <90% over last 6 months, smallest non-F&O stocks replaced by F&O-eligible (max 50), or failing 1.5x free-float market cap threshold vs. smallest constituent |
| Factor Basis | Sector/Theme |
| Universe | Nifty 500 Index which represent Healthcare sector. |
| Weightage | Free-Float Market Cap Weighting; Max weight = 10% |
| Stocks Included | Top 50 companies from Nifty 500's Healthcare sector, ranked by 6-month average free-float market cap, preference to F&O-traded stocks followed by non-F&O stocks if required. |
| Exclusions | Stocks moving out of Nifty 500, trading frequency <90% over last 6 months, smallest non-F&O stocks replaced by F&O-eligible (max 50), or failing 1.5x free-float market cap threshold vs. smallest constituent |
Fund • Last updated: 25/10/2026